Skip to main content

Table 3 Mutation frequency in the lacZ and cII genes from the liver of Muta™ mice treated with 2,5-, 2,6- and 3,5-DMAs

From: Mutagenic properties of dimethylaniline isomers in mice as evaluated by comet, micronucleus and transgenic mutation assays

Animal ID

lacZ

cII

Total plaquesa

Mutants

MF (× 106)

Mean ± SD

Total plaquesa

Mutants

MF (× 106)

Mean ± SD

Control (olive oil)

41

418,500

44

105.1

 

1,114,800

44

39.5

 

42

233,000

21

90.1

 

1,129,500

33

29.2

 

43

709,500

66

93.0

 

1,346,400

45

33.4

 

44

444,500

63

141.7

 

2,203,200

173

78.5

 

45

1,057,500

104

98.3

 

2,798,400

77

27.5

 

Total

2,863,000

298

104.0

105.7 ± 18.7

8,592,300

372

43.3

41.6 ± 18.9

2,5- DMA

81

331,250

38

114.7

 

1,257,000

56

44.6

 

82

165,000

15

90.9

 

846,000

27

31.9

 

83

639,000

26

40.7

 

892,800

21

23.5

 

84

2,109,000

220

104.3

 

2,120,400

129

60.8

 

85

(87000)

10

114.9

 

129,000

6

46.5

 

Total

3,348,750

310

92.6

87.7 ± 28.4

5,245,200

239

45.6

41.5 ± 12.8

2,6- DMA

91

573,000

72

125.7

 

1,473,600

41

27.8

 

92

840,000

76

90.5

 

2,028,000

72

35.5

 

93

2,826,000

230

81.4

 

945,000

25

26.5

 

94

2,435,000

193

79.3

 

3,013,800

164

54.4

 

95

131,250

11

83.8

 

612,000

11

18.0

 

Total

6,805,250

582

85.5

92.1 ± 17.2

8,072,400

313

38.8

32.4 ± 12.3

3,5- DMA

101

1,053,000

100

95.0

 

2,167,200

72

33.2

 

102

277,500

24

86.5

 

1,095,000

30

27.4

 

103

2,111,000

170

80.5

 

2,426,400

95

39.2

 

104

2,723,000

234

85.9

 

2,522,400

129

51.1

 

105

1,641,000

184

112.1

 

1,960,800

71

36.2

 

Total

7,805,500

712

91.2

92.0 ± 11.1

10,171,800

397

39.0

37.4 ± 7.9

  1. aData with at least 100,000 total plaques were evaluated by the statistical analysis and a parenthesis indicates exclusion